Infosys Limited has formally released its audited standalone and consolidated financial statements for the quarter and year ended March 31, 2026. Following the Board Meeting held on April 23, 2026, the company has submitted the auditor’s reports to all stock exchanges. These documents detail the company’s financial health, audit procedures regarding revenue recognition, and list the numerous global entities that constitute the group’s consolidated operations.
Audit Overview
Following the Board of Directors meeting conducted on April 23, 2026, Infosys Limited has published its comprehensive audit reports for the fiscal year ending March 31, 2026. These reports cover both standalone and consolidated financial results, providing transparency into the company’s operational performance and financial standing.
Revenue Recognition and Audit Focus
The independent auditor, Deloitte Haskins & Sells LLP, has identified key audit matters of primary significance. The primary focus remains on revenue recognition across the company’s complex portfolio of IT services, which includes software development, consulting, and package implementation. The audit process specifically evaluated:
- The identification of distinct performance obligations within multi-product customer contracts.
- The determination of the company’s role as either a principal or agent in integrated services arrangements.
- The application of percentage-of-completion methods versus straight-line recognition for fixed-price maintenance contracts.
Governance and Controls
The audit confirms that the company maintains an adequate internal financial control system commensurate with its size and the nature of its business. The report indicates no material fraud and highlights that the company remains compliant with all relevant regulatory requirements, including Corporate Social Responsibility (CSR) obligations and statutory dues.
Consolidated Operations
The group operates through a extensive network of 139 subsidiaries and entities across the globe, ranging from Infosys Technologies (China) to BASE life science and various in-tech subsidiaries acquired throughout the year. The report ensures that the consolidated financial statements accurately reflect the state of affairs for the entire group as of March 31, 2026.
Source: BSE
